Cheryl V. Reicin

Cheryl V. Reicin

Partner
New York: 212.880.6067
Toronto: 416.865.7373
Fax 212.682.0200

Education

JD, 1984
Harvard Law School
BA (summa cum laude), 1980
Barnard College, Columbia University

Bar Admissions

Massachusetts, 1989 New York, 1985 Foreign Legal Consultant, Ontario, 2005

Overview

"Great to work with, is creative, is whip-smart, so you can trust that she will reach the right conclusions." - LMG Life Sciences

Cheryl Reicin's practice focuses on biotechnology, medical device, health information and other technology-based companies, and representation of private equity/venture capital funds and investment banks that fund such companies. She also represents academic medical centers and universities. Her practice centers on U.S., Canadian and Israeli entities.

Cheryl assists companies in formulating domestic and international growth strategies and in sourcing capital. She advises on venture and later-stage financings, IPOs, mergers and acquisitions, licensing transactions and joint ventures or alliances with strategic partners. She also coordinates domestic and international structuring, intellectual property planning and regulatory strategy.

Representative Work

Load More

Recognition

Women's Executive Network (WXN) 2016 Canada's Most Powerful Women: Top 100 Award (2016)

Best Lawyers' Best Lawyers in Canada—Leading lawyer in biotechnology law (2010-2017)

Chambers & Partners’ Chambers Canada—Leading lawyer in Canada, life science (2017)

Law Business Research’s Who’s Who Legal Canada and New York—Leading lawyer in life sciences (2010-2016)

Women of Influence, 2013 and 2014—Canada’s Top 25 Women of Influence (No. 1 in Professional Services category)

Expert Guides' Women in Business Law Guide—Leading practitioner in life sciences (2014-2016)

LMG Life Sciences, 2013—Finance & Transactional Lawyer of the Year

Best Lawyers in Canada, 2014—Biotechnology Law Lawyer of the Year

Law Business Research’s International Who’s Who of Life Sciences Lawyers—Leading U.S. lawyer in transactional law (2010-2014)

Law Business Research’s Who’s Who Legal: International Who’s Who of Business Lawyers—Leading lawyer in life sciences (2010-2014)

Intellectual Asset Management's IAM Patent 1000: The World's Leading IP Transactions —Leading lawyer globally (2012-2016)

Lexpert/Thomson Reuters Canada’s Canadian Legal Lexpert Directory —Repeatedly recommended practitioner in biotechnology (2013-2017)

Intellectual Asset Management's IAM Licensing 250: The World's Leading Patent and Technology Licensing Lawyers 2010 and 2011/12—Leading lawyer globally

Practical Law Company’s Which Lawyer? 2012—Leading lawyer in life sciences: corporate and commercial

Lexpert/Thomson Reuters Canada’s Canadian Legal Lexpert Directory 2012—Repeatedly recommended practitioner in biotechnology and technology transactions

Lexpert/Thomson Reuters Canada’s Canadian Legal Lexpert Directory 2011—Consistently recommended practitioner in biotechnology

Practical Law Company’s Which Lawyer? Yearbook 2010 and 2011—Highly recommended lawyer in life sciences: corporate and commercial

Lexpert/Thomson's Canadian Legal Directory 2008, 2009 and 2010—Repeatedly recommended practitioner in biotechnology

Lexpert/American Lawyer Media’s Guide to the Leading 500 Lawyers in Canada 2006—Leading practitioner in serving the corporate midmarket

Insights

Disruptors Speaker Series

Genesis

Building a Business Plan for Your Israeli Start-Up

Richard Ivey School of Business

Tapping U.S. Markets: Confidentially Marketed Public Offerings

Capital Markets 2015 Mid-Year Report

Media

Professional Involvement

Before joining Torys, Cheryl was a partner of a large international law firm, where she chaired an 85-attorney life sciences group.

Directorships

Current Directorships

  • The Hospital for Sick Children (Trustee)
  • Institute for the Study of Aging (Business Advisory Board)
  • Genesis, incubator for social entrepreneurship (Chair and Founder)
  • Health Technologies Fund (External Review Panel (ERP)
  • The Centre for Israel and Jewish Affairs (Director)

Past Directorships

  • PREVENT (Pan-Provincial Vaccine Enterprise Inc.) (Director)
  • Health Technology Exchange (HTX) (Advisory Board)
  • Alzheimer’s Drug Discovery Foundation (Director)
  • OCE/CQDM Life Sciences R&D Challenge (Review Panel)
  • Hadassit, the technology transfer subsidiary of Hadassah Medical Center, Jerusalem (Advisory Board)
  • Journal of BioLaw and Business (Editorial Advisory Board)
  • Entrepreneurship Institute (Director)
  • Ontario Genomics Institute (Director)
  • Artists 4 Israel (Director)
  • Baycrest Centre for Geriatric Care (Research Advisory Committee)
  • Jerusalem College of Technology (Director)
  • BIO International Committee